Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | February 2022

An Interview With Eric A. Secemsky, MD, MSc

Dr. Secemsky discusses his work with FDA using Medicare data in SAFE-PAD and SAFE-AAA, how a statistical education and mentor relationships were formative to his career, his experience with PERTs, and his perspective on how to increase the breadth of evidence for peripheral vascular disorders.

evt | Article | April 2026

Excellence in Action

By Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

evt | Article | January 2023

Creative, Collaborative Approaches

By Anahita Dua, MD, MBA, MSc, and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

evt | Article | September 2020

Update on SFA Interventions

By Yann Gouëffic, MD, PhD, and Eric A. Secemsky, MD, MSc

Advertisement

Advertisement

evt | Article | August 2025

Exploring the Effects of the Paclitaxel Pause

Dr. Secemsky discusses patient perspectives, recent study findings, and the evolving peripheral market.

With Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

evt | Article | May 2025

Study Finds Large Interhospital Variability for CLTI Revascularization

With Aishwarya Raja, MD; Fadi Saab, MD, FACC, FASE, FSCAI; and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

evt | Article | January 2023

Current Evidence for Catheter-Based Renal Denervation for Hypertension

A review of the evidence for a novel treatment for hypertension.

By Anna K. Krawisz, MD, and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

Sponsored by The PERT Consortium®

evt | Article | July 2021 Supplement

The Promise of The PERT Consortium® PE Registry

A registry to inform physicians about the modern state of pulmonary embolism care, including risk stratification, diagnosis, and treatment.

By Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; Jay Giri, MD, MPH; and Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM

evt | Article | September 2022

Role of Intravascular Ultrasound in Superficial Femoral Artery Interventions

An update on emerging evidence on the use of IVUS in SFA interventions.

By Ramya C. Mosarla, MD, and Eric A. Secemsky, MD, MSc

Sponsored by Medtronic

evt | Article | January 2025

Roundtable Discussion on the Current State of Atherectomy for Lower Extremity Arterial Disease

With Jeffrey Carr, MD; Ralf Langhoff, MD; and Eric A. Secemsky, MD, MSc

Sponsored by Shockwave Medical

evt | Article | January 2024 Supplement

Achieving Success in Calcified SFA and Popliteal Lesions

Multidisciplinary perspectives and optimal approaches to real-world scenarios.

With Carlos J. Guevara, MD, FSIR; Leigh Ann O’Banion, MD; and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

evt | Article | May 2024

CLTI Preamputation Care Pathways

Reflections on an analysis of CLTI care trends highlight areas where pre- and postamputation care need to evolve, efforts to make CLTI care more uniform and equitable, and more.

With Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; Lee Kirksey, MD, MBA; and Elina Quiroga, MD, MPH

evt | Article | January 2025

SAFE-IVC Study Finds Declining Use of IVC Filters But Need for Improved Rates of Timely Retrieval

By Enrico G. Ferro, MD, and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

Sponsored by Shockwave Medical

evt | Article | March 2023

Achieving Success in Calcified SFA and Popliteal Lesions

Multidisciplinary perspectives and optimal approaches to real-world scenarios.

With Carlos J. Guevara, MD, FSIR; Leigh Ann O’Banion, MD; and Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

evt | Article | September 2020

Patient-Centered Care for PAD: Individualizing Treatment Strategies for Claudication

An overview of the aims of an NHLBI grant to evaluate shared decision-making in routine PAD care.

By Anna Krawisz, MD, and Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM

evt | Article | September 2021

A Safety Update on Paclitaxel-Coated Devices for Peripheral Vascular Intervention

An overview of the controversy surrounding a late mortality signal associated with paclitaxel-coated devices and an exploration of new data regarding their safety.

By Anna Krawisz, MD, and Eric A. Secemsky, MD, MSc

evt | Article | September 2019

Real-World Data Collection Regarding Paclitaxel Treatment

An overview of why real-world data are pertinent to the safety assessment of paclitaxel-coated devices, with separate summaries of the projects investigating the late mortality signal via real-world data analyses.

By Anna Krawisz, MD, and Eric A. Secemsky, MD

evt | Article | July 2024

Ask The Experts: What Does PE Intervention Look Like in 2034?

Experts consider the role of PERTs, technologic advances, and the state of research and data in the next 10 years.

With Brent Keeling, MD; Robert A. Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; and Frances Mae West, MD, MS, FACP

evt | News | December 5, 2017

Nationwide Cohort Study Evaluates Readmissions After Revascularization Procedures for PAD

December 6, 2017—In Annals of Internal Medicine, Eric A. Secemsky, MD, et al published findings online from a retrospective cohort study that sought to evaluate nationwide readmissions after revascularization for peripheral artery disease (PAD) and to assess whether readmission risk varies among hospitals. The background of the investigation is that limited data suggest high rates of unplanned rehospitalization after endovascular and surgical revascularization for PAD; however, the overall burden of readmissions has not been comprehensively explored.

evt | News | February 13, 2019

No Evidence of Paclitaxel-Related Increased Mortality Found in Medicare Database Analysis at 600 Days

February 14, 2019—A study published online in JAMA Cardiology by Eric A. Secemsky, MD, et al showed no evidence of increased all-cause mortality following femoropopliteal artery revascularization using paclitaxel drug-eluting stents (DESs) or drug-coated balloons (DCBs) versus non–drug-coated devices. The study seeks to explore concerns raised by the meta-analysis by Katsanos et al regarding the potential for increased mortality associated with the use of paclitaxel in patients with peripheral artery disease.


1
2
3
4

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button